Although COVID-19 has Dampened Pharma Sales in 2020, Outlook to 2026 is still Optimistic
Sydney Otomancek2020-08-17T13:03:39-04:00August 17th, 2020|Categories: Featured, Industry News|Tags: COVID-19, EvaluatePharma, forecast, HEOR, outlook, report|
According to the EvaluatePharma World Preview 2020, Outlook to 2026 report, COVID-19 has reduced biopharma sales forecasts by $7.85bn with [...]
Receive essential insights, resources and content direct to your inbox!
Hit subscribe to stay informed!
Advertisement
Latest News
Featured Webinars
Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters
Tuesday, December 5, 2023
Sponsor: ICON
EU HTA Joint Clinical Assessments: Navigating Potential Challenges Ahead of 2025
Friday, November 10, 2023
Sponsor: OpenHealth
Cell & Gene Therapies – Beginning with the End in Mind
Thursday, November 2, 2023
Sponsor: Magnolia Market Access
Categories
Artificial Intelligence
Careers
Clinical Trials
Cost Effectiveness
Data Analytics & Syndicated Reports
Healthcare Financing
Health Databases
Health Equity
Health Policy
Health Tech Assessment
Integrated Evidence Assessment & Planning
Market Access
Medical Affairs
Patient Outcomes & Engagement
Pricing & Reimbursement
Real World Data
Real World Evidence
Value Assessment
Value Communication